ClinConnect ClinConnect Logo
Search / Trial NCT02589938

Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Oct 27, 2015

Trial Information

Current as of June 09, 2025

Completed

Keywords

Hypopharyngeal Cancer Laryngeal Cancer Lip And Oral Cavity Cancer Nasopharyngeal Cancer Oropharyngeal Cancer Paranasal Sinus And Nasal Cavity Cancer Salivary Gland Cancer Radiation Toxicity Xerostomia Long Term Effects Of Cancer Treatment Oral Complications Of Radiation Therapy

ClinConnect Summary

Patients who have met all eligibility criteria will be randomized to standard oral hygiene, standard oral hygiene + true acupuncture twice weekly for 4 weeks, or standard oral hygiene + sham acupuncture twice weekly for 4 weeks by a form of adaptive randomization, called minimization, because simple randomization could result in covariate imbalances .

The acupuncture points will be at three sites on each ear (Shenmen, Point Zero, Salivary Gland 2-prime), a site on the chin (CV24), a site on each forearm (Lu7), a site on each hand (LI 1-prime), a site on each leg (K6), and one placebo needl...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Must be at least 18 years of age and able to give informed consent.
  • Must be able to read, write and understand English.
  • Must have a diagnosis of head/neck cancer.
  • * Must have received bilateral radiation therapy, and subsequently developed grade 2 or 3 xerostomia, according to modified Radiation Therapy Oncology Group (RTOG) scale:
  • Grade 0 - None
  • Grade 1 - Slight dryness of mouth (good response on stimulation and no significant dietary alterations necessary)
  • Grade 2 - Moderate dryness of mouth (poor response on stimulation and altered oral intake required such as frequent water, oral lubricants, or soft-moist foods)
  • Grade 3 - Complete dryness of mouth (no response on stimulation and difficult oral alimentation; IV fluids, pureed diet or tube feedings may be required)
  • Grade 4 - Fibrosis
  • Must have received external beam radiation at a mean dose of at least 24 Gy to one of the parotid glands. The other gland can receive less than 24 Gy.
  • Must have completed radiotherapy at least 12 months prior to entry.
  • Must have anatomically intact parotid and submandibular glands. A focused (head/neck) history and exam conducted by a physician or dentist within the past year is required.
  • Must be acupuncture naïve.
  • Must have Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.
  • Exclusion Criteria:
  • History of xerostomia, Sjogren's disease or other illness known to affect salivation prior to head/neck radiation.
  • Suspected or known closure of salivary gland ducts on either side. (Patients addressed in inclusion criteria (i.e. those who have had one submandibular gland removed) are expected to have closure to the removed submandibular gland and will be exempt from this exclusion criteria.)
  • Currently receiving or planning to use drugs, herbs, alternative medicines, or devices that could affect salivary production. Treatment known to affect salivation should be stopped at least 14 days prior to enrollment. Over the counter products used for salivary substitution are allowed, but will need to be discontinued for at least 24 hours prior to saliva and questionnaire data collection.
  • Have received any investigational new drug within the past 30 days or planning to receive such during the study period.
  • Active systemic infection or skin infection at or near the acupuncture sites.
  • Receiving chemotherapy during study period.

About Wake Forest University Health Sciences

Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.

Locations

Edina, Minnesota, United States

Houston, Texas, United States

Chillicothe, Ohio, United States

Coon Rapids, Minnesota, United States

Portland, Oregon, United States

Honolulu, Hawaii, United States

Minneapolis, Minnesota, United States

Honolulu, Hawaii, United States

Winston Salem, North Carolina, United States

Saint Louis Park, Minnesota, United States

Albuquerque, New Mexico, United States

Cedar Rapids, Iowa, United States

Nashville, Tennessee, United States

Burbank, California, United States

San Francisco, California, United States

San Jose, California, United States

San Rafael, California, United States

Santa Clara, California, United States

Santa Rosa, California, United States

South San Francisco, California, United States

Walnut Creek, California, United States

Honolulu, Hawaii, United States

Grand Rapids, Michigan, United States

Grand Rapids, Michigan, United States

Chicago, Illinois, United States

Cedar Rapids, Iowa, United States

Greenville, South Carolina, United States

Greenville, South Carolina, United States

Boiling Springs, South Carolina, United States

Seneca, South Carolina, United States

Santa Fe, New Mexico, United States

Lacey, Washington, United States

Columbus, Ohio, United States

Conroe, Texas, United States

Houston, Texas, United States

San Rafael, California, United States

Patients applied

0 patients applied

Trial Officials

Suzanne C Danhauer, PhD

Principal Investigator

Wake Forest University Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials